SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-020163
Filing Date
2021-08-16
Accepted
2021-08-16 16:10:32
Documents
15
Period of Report
2021-08-16
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 41220
2 ex99-1.htm EX-99.1 260412
3 ex99-1_01.jpg GRAPHIC 6840
4 ex99-2.htm EX-99.2 171199
  Complete submission text file 0001493152-21-020163.txt   713084

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE indp-20210816.xsd EX-101.SCH 3030
6 XBRL LABEL FILE indp-20210816_lab.xml EX-101.LAB 34239
7 XBRL PRESENTATION FILE indp-20210816_pre.xml EX-101.PRE 22362
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3791
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 347-480-9760
Indaptus Therapeutics, Inc. (Filer) CIK: 0001857044 (see all company filings)

IRS No.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40652 | Film No.: 211178205
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences